Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives

Mattson, M. P.·1997·Physiological Reviews

Cited by (999)

Items 801–900 of 999

  1. Rho-associated kinases contribute to the regulation of tau phosphorylation and amyloid metabolism during neuronal plasticity
    Hatice Saray, Cem Süer, Bilal Koşar, Burak Tan, Nurcan Dursun · 2021 · Pharmacological Reports
  2. Neuroprotective and anticancer effects of 7‑Methoxyheptaphylline via the TAK1 pathway
    Chantana Boonyarat, Mongkhonphan Tantiwatcharakunthon, Pitchayakarn Takomthong · 2022 · Oncology Reports
  3. NEUROINFLAMMATION IN ALZHEIMER’S DISEASE AND INVOLVEMENT OF INTERLEUKIN-1: A MECHANISTIC VIEW
    Vivek Sharma · 2011 · International Journal of Pharmaceutical Sciences and Drug Research
  4. Mechanisms of Excitotoxicity and Excitoprotection
    Mark P. Mattson · 2004 · Springer eBooks
  5. Acidic-rich region of amyloid precursor protein induces glial cell apoptosis
    Kai Sun, G.-H. SUN, Yi‐Chang Su, Chung‐I Chang, Mei-Jan Chuang, Wan-Lin Wu, C.-Y. Chu, Shanshan Tang · 2004 · APOPTOSIS
  6. Presenilin-1/γ-Secretase Controls Glutamate Release, Tyrosine Phosphorylation, and Surface Expression of N-Methyl-d-aspartate Receptor (NMDAR) Subunit GluN2B
    Xuan Zhao, Gaël Barthet, Junichi Shioi, Jindong Xu, Anastasios Georgakopoulos, Julien Bruban, Nikolaos K. R K Robakis · 2013 · Journal of Biological Chemistry
  7. Rapid Inhibition by Sodium Azide of the Phosphoinositide-Mediated Calcium Response to Serotonin Stimulation in Human Platelets: Preservation in Alzheimer's Disease
    Henrietta L.M. Hedin, Sture Eriksson, Christopher John Fowler · 2000 · Biochemical and Biophysical Research Communications
  8. Molecular Aspects of Memory Dysfunction in Alzheimer’s Disease
    Jeannie Chin, Erik D. Roberson, Lennart Mucke · 2008 · Elsevier eBooks
  9. Heme Oxygenase-1 and Alzheimer Disease
    Yogesh R. Mawal, Daniel Berlin, Steven Kravitz, Hyman M. Schipper · 2002 · Springer eBooks
  10. APP Biology, Processing and Function
    Gopal Thinakaran, Edward H. Koo · 2007 · Springer eBooks
  11. Inflammation, Free Radicals, Glycation, Metabolism and Apoptosis, and Heavy Metals
    Mark P. Mattson · 2001 · Elsevier eBooks
  12. Chapter 3. β-Amyloid as a Target for Alzheimer's Disease Therapy
    Corinne E. Augelli‐Szafran, Lary C. Walker, Harry LeVine · 1999 · Annual reports in medicinal chemistry
  13. The secretion of soluble amyloid beta precursor protein (AβPPs) by chick neurons in serum-free primary culture is not regulated by protein kinase C
    Henrietta L.M. Hedin, Âsa Näsman, Christopher James Fowler · 1998 · Amyloid
  14. Sepsis-Associated Brain Dysfunction: Mechanisms, Clinical Insights, and Therapeutic Strategies
    Nazrana Payal, Juhi Saxena, Vijay Kumar Srivatsava, Sanket Kaushik, Arif Jamal Siddiqui, Kartik Chauhan, Aditi Sharma, Anupam Jyoti, Lalit Sharma · 2025 · Current Drug Targets
  15. INFLUENCE OF β-AMYLOID PEPTIDE ON PLASMALEMMAL CALCIUM CHANNELS OF HIPPOCAMPAL CELL CULTURE [
    T. Yu. Korol’, Elena P. Kostyuk, Platon G. Kostyuk · 2009 · Fìzìologìčnij žurnal
  16. Homocysteine—Potential Novel Diagnostic Indicator of Health and Disease in Horses
    Marcin Gołyński, Michał Metyk, Jagoda Ciszewska · 2023 · Animals
  17. Is there room for Darwinian medicine and the hygiene hypothesis in Alzheimer pathogenesis?
    W. Sue T. Griffin, Robert Emil Mrak · 2009 · Birkhäuser Basel eBooks
  18. The neuropathology of stillbirth — Correlation with apolipoprotein genotype in a Scottish population based study
    Jeanne E. Bell, Julie‐Clare Becher, Jean W. Keeling, Neil McIntosh · 2015 · Early Human Development
  19. Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model
    Kunié Ando, Andreea‐Claudia Kosa, Yasmina Mehadji, Hinde Lasri, Lidia Lopez‐Gutierrez, Carolina Quintanilla‐Sánchez, Emmanuel Aydin, Emilie Doeraene, Alain Wathelet‐Depauw, Siranjeevi Nagaraj et al. · 2025 · Biomolecules
  20. Deletion of Dcf1 Reduces Amyloid-β Aggregation and Mitigates Memory Deficits
    Weihao Li, Linhua Gan, Fang-fang Ma, Ruili Feng, Jiao Wang, Yanhui Li, Yangyang Sun, Ya-jiang Wang, Xin Diao, Fei-yang Qian et al. · 2021 · Journal of Alzheimer s Disease
  21. Peripheral Markers of Alzheimer’s
    Maire E. Percy, David F. Andrews, Huntington Potter · 2000 · Humana Press eBooks
  22. Differential expression of β-amyloid precursor and Bcl-2 proto-oncogene proteins in the developing dog retina
    Shur-Tzu Chen, Jiang-Ping Wang, Chi‐Hsien Chien · 1999 · Neuroscience Research
  23. Metales de transición y enfermedad de Alzheimer
    Carlos Opazo · 2005 · Revista Española de Geriatría y Gerontología
  24. Justicidin A Reduces β-Amyloid via Inhibiting Endocytosis of β-Amyloid Precursor Protein
    Yoon Sun Chun, Oh-Hoon Kwon, Hyun Geun Oh, Yoon Young Cho, Hyun Ok Yang, Sungkwon Chung · 2018 · Biomolecules & Therapeutics
  25. How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art
    2017 · BENTHAM SCIENCE PUBLISHERS eBooks
  26. Genetic Factors and the Role of Calcium in Alzheimer’s Disease Pathogenesis
    Mervyn J. Monteiro, Stacy Marie Stabler · 2000 · Springer eBooks
  27. Amyloid ? peptides mediate physiological remodelling of the acute O sensitivity of adrenomedullary chromaffin cells following chronic hypoxia
    S BROWN, R JOHNSON, Rhandi Senaratne · 2004 · Cardiovascular Research
  28. A plausible function of the prion protein: conjectures and a hypothesis
    Yousef H. Abdulla · 2001 · BioEssays
  29. 6β-Acetoxy nortropane regulated processing of amyloid precursor protein in CHOm1 cells and rat brain
    Yu Lan Qiu, Hongzhuan Chen, Xing-Jun Wu, Zheng-jun Jin · 2003 · European Journal of Pharmacology
  30. Mechanisms of Neuronal Apoptosis and Excitotoxicity
    Sana Mostafa · 2024 · Springer eBooks
  31. Evidence that cholinergic mechanisms contribute to hyperexcitability at early stages in Alzheimer’s disease
    Helen E. Scharfman, Korey Kam, Áine Duffy, John J. LaFrancois, Paige Leary, Elissavet Chartampila, Stephen D. Ginsberg, Christos Panagiotis Lisgaras · 2025 · Frontiers in Dementia
  32. Comprehensive High-Depth Proteomic Analysis of Plasma Extracellular Vesicles Containing Preparations in Rett Syndrome
    Sho Hagiwara, Tadashi Shiohama, Satoru Takahashi, Masaki Ishikawa, Yusuke Kawashima, Hironori Sato, Daisuke Sawada, Tomoko Uchida, Hideki Uchikawa, Hironobu Kobayashi et al. · 2024 · Biomedicines
  33. Restoring neuronal excitability and spatial memory through inhibiting amyloid-β-induced hyperactive NF-κB in a rat model of Alzheimer’s disease
    Zahra Soleimani, Shima Davoudi, Fatemeh Saffarzadeh, Gila Behzadi, Mehdi Mehdizadeh, Mona Rahdar, Narges Hosseinmardi, Mahyar Janahmadi, Mohammad Javad Eslamizade · 2025 · Brain Research
  34. Dietary Folate, B Vitamins and The Brain: The Homocysteine Connection
    Mark P. Mattson, Inna I. Kruman, Wenzhen Duan · 2002 · Springer eBooks
  35. Mitochondrial oxidative stress and metabolic alterations in neurodegenerative disorders
    Jeffrey N. Keller, Gordon W. Glazner · 2001 · Advances in cell aging and gerontology
  36. The amyloid-β precursor-like protein APLP2 and its relative APP are differentially regulated during neuroendocrine cell activation
    Rob W.J. Collin, Gerard J.M. Martens · 2005 · Molecular and Cellular Neuroscience
  37. The Amyloid _-Protein and Alzheimer's Disease
    David B. Teplow, Mingfeng Yang, Robin Roychaudhuri, Eric S. Pang, Tien‐Phat V. Huynh, Mei‐Sha Chen, Shiela Beroukhim · 2012 · Frontiers in neuroscience
  38. Oxidative Stress, Metabolic Syndrome and Alzheimer’s Disease
    Danira Toral-Ríos, Karla Carvajal, Bryan Víctor Phillips-Farfán, Luz Camacho, Victoria Campos‐Peña · 2016 · Springer eBooks
  39. Metal Transporters in Neurodegeneration
    Hong Fu Jiang · 2017 · Elsevier eBooks
  40. Brain damage in sheep from penetrating captive bolt stunning
    JW FINNIE, Jim Manavis, P. C. Blumbergs · 2002 · Australian Veterinary Journal
  41. Cellular and Molecular Mechanisms Underlying Synaptic Degeneration and Neuronal Death in Alzheimer's Disease
    Mark P. Mattson, Ward A. Pedersen, Carsten Culmsee · 2001 · Humana Press eBooks
  42. Mitochondrial ROS Production Initiates Aβ1-40-Mediated Up-Regulation of L-Type Ca2+ Channels during Chronic Hypoxia
    Ian M. Fearon, Stephen T. Brown, Kristin Hudasek, Jason L. Scragg, John P. Boyle, Chris Peers · 2006 · Springer eBooks
  43. Par-4 in Neuronal Death and Survival in Alzheimer’s Disease and Other Neurogenerative Diseases
    Qing Guo, Jun Xie, Chelsea J. Guo · 2021 · Springer eBooks
  44. Antioxidant Genes and Reactive Oxygen Species in Down's Syndrome
    Cécile Bladier, Judy B. de Haan, Ismail Kola · 2000 · Elsevier eBooks
  45. Neuronal Protein Trafficking in Alzheimer's Disease and Niemann-Pick Type C Disease
    Anne M. Cataldo, Ralph A. Nixon · 2007 · Elsevier eBooks
  46. Telomerase, DNA damage and apoptosis
    Mark P. Mattson, Weiming Fu, Peisu Zhang · 2001 · Advances in cell aging and gerontology
  47. Purification by column chromatographies of beta-amyloid precursor proteins and their association with other 95 kDa protein in rat brain
    Takeyuki Ohshita, 晃子 中谷, Yuzo HIROI · 1998 · Journal of Chromatography B Biomedical Sciences and Applications
  48. Toxicity Study in Alzheimer's Disease Cell Model
    Vicky Rulando Suryadi · 2014
  49. Neurotoxic Oxidative Metabolite of Serotonin
    Ladislav Volicer, Monika Z. Wrona, Wayne R. Matson, Glenn Dryhurst · 2007 · Humana Press eBooks
  50. Neurotransmitter Receptor—G-Protein-Mediated Signal Transduction in Alzheimer’s Disease
    Richard F. Cowburn · 2000
  51. Recent Trends in Drug Discovery against Alzheimer's Disease: Use of Natural Products and Nutraceuticals from Botanicals
    Sudatta Maity, Samapika Nandy, Anuradha Mukherjee Abhijit Dey · 2018
  52. Animal Models of Neurodegenerative Diseases
    Imad Ghorayeb, Guylène Page, Afsaneh Gaillard, Mohamed Jaber · 2010 · Advances in neurobiology
  53. β-amyloid(25-35) inhibits the activity of inositol (1,4,5)-trisphosphate-5-phosphatase
    Annica Rönnbäck, Christopher James Fowler · 2000 · Amyloid
  54. Proponiendo biomarcadores para evaluar las alteraciones en la homeostasis cerebral de hierro y su relación con la fisiopatología de la Enfermedad de Alzheimer
    Alexis Tapia S · 2007 · Revista chilena de neuro-psiquiatría
  55. Distribution of a Human Brain Carboxypeptidase B Capable of Cleaving .BETA.-Amyloid Precursor Protein (APP) in Normal and Aizheimer's Diseased Brain.
    Kyoko Itoh, Akira Matsumoto · 2001 · ACTA HISTOCHEMICA ET CYTOCHEMICA
  56. Effects of Polygalae Radix on β-Amyloid Accumulation and Memory Impairment Induced by Chronic Cerebral Hypoperfusion in Rats
    Young-Ha Son, Sungjae Kim, Min-Chan Chung, Dong-Guk Cho, Woo-Sung Cho, Jung-Won Shin, Dong Il Park, Nak‐Won Sohn · 2014 · The Korea Journal of Herbology
  57. Prostate apoptosis response-4 (Par-4): an emerging target for Alzheimer’s and Parkinson’s diseases and stroke
    Mark P. Mattson · 2000 · Emerging Therapeutic Targets
  58. Alzheimer's disease and Glucose Metabolism
    Liangyan Hu, Shufei Zhuang · 2014
  59. Oxidative Stress in Down Syndrome
    Rocco C. Iannello, Ismail Kola · 2001 · Humana Press eBooks
  60. An Epigenetic Model for Susceptibility to Oxidative DNA Damage in the Aging Brain and Alzheimer’s Disease
    Nasser H. Zawia, Fernando Cardozo‐Pelaez · 2010 · Humana Press eBooks
  61. Pathological Validation of Animal Models of Dementia
    Daniel Nicolae Pirici, Christine Van Broeckhoven, Samir Kumar‐Singh · 2010 · Neuromethods
  62. Effect of caffeine on Alzheimer’s molecular factors in correlation with involved cell communication systems in developing zebrafish Danio rerio
    Tamer Said Abdelkader, Seo‐Na Chang, Ji-Min Lee, JuHa Song, Hanseul Oh, Jae‐Hak Park · 2015 · Journal of Laboratory Medicine
  63. Molecular Mechanisms of Synaptic Plasticity and Memory and Their Dysfunction in Alzheimer's Disease ☆
    Gabriel S. Stephens, Jason C. You, Chia-Hsuan Fu, Jeannie Chin · 2017 · Elsevier eBooks
  64. Down Syndrome, Antioxidant Balance and the “Gene Dosage Effect” Hypothesis
    Judy B. de Haan, Peter John Crack, Melanie A. Pritchard, Ismail Kola · 2007 · Elsevier eBooks
  65. "Effects of Massage Therapy and the Role of Physical Activity as an Improvement in the Psycho-Physical State of the Individual and Reduction of Pain and Anxiety During the Covid-19 Pandemic Systematic Review"
    Dario Furnari · 2022 · Biomedical Journal of Scientific & Technical Research
  66. Nutritional Support System (NSS) as a New Therapeutic Strategy for Cerebral Palsy
    Fernando Leal-Martínez, Guadalupe Jimenez Ramirez, Antonio Ibarra · 2023 · CNS & Neurological Disorders - Drug Targets
  67. Structural and molecular insights into tacrine-benzofuran hybrid induced inhibition of amyloid-β peptide aggregation and BACE1 activity
    Rajdeep Kaur, Simranjeet Singh Narang, Pritpal Singh, Bhupesh Goyal · 2023 · Journal of Biomolecular Structure and Dynamics
  68. STARRING ROLE OF MITOCHONDRIAL IMPAIRMENT IN ALZHEIMER’S DISEASE NEUROPATHOLOGY
    Ayesha Yousaf, Farah Deeba, Sidra Younis, Nadia Iqbal, Farheen Aslam · 2022 · THE JOURNAL OF MICROBIOLOGY AND MOLECULAR GENETICS
  69. El péptido β-amiloide: mecanismos de neurotoxicidad. neuroprotección por antioxidantes y estrógenos
    F.J. Muñoz López · 2001 · Revista Española de Geriatría y Gerontología
  70. Epigenetics and Late-Onset Alzheimer’s Disease
    Axel Schumacher, Syed Waseem Bihaqi, Nasser H. Zawia · 2011 · Springer eBooks
  71. Natural Intracellular Consequences of Amyloid
    Michael R. D’Andrea · 2016 · Elsevier eBooks
  72. Alzheimer’s Disease
    Jacques Fantini, Nouara Yahi · 2015 · Elsevier eBooks
  73. Characterization of the influence of Amyloid β (1-42) By Way of Modeling Synaptic Cleft with an RC Electronic Circuit
    Mehmet Emin Tagluk, İbrahim Işık · 2020 · DÜMF Mühendislik Dergisi
  74. Increasing Brain Healthspan by Dietary Restriction
    Mark P. Mattson, Jaewon Lee · 2002 · Springer eBooks
  75. Whole Blood Samples from Alzheimer Patients and Control Donors Demonstrate Fluorimetric Differences
    András Palotás, Janos L. Kalman, Miklós Palotás · 2002 · Neurochemical Research
  76. Alzheimer's Disease: Search for Therapeutics
    Waclaw J. Rzeszotarski · 2003 · Wiley eBooks
  77. Proteolytic processing of the Alzheimer APP protein family during neuronal differentiation
    Sofia Holback · 2009 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  78. Glial heme oxygenase-1 in CNSinjury and disease
    Hyman M. Schipper · 2003 · Advances in molecular and cell biology
  79. γ‐Secretase Inhibition: An Overview of Development of Inhibitors for the Treatment of Alzheimer's Disease
    Christopher L. Hamblett, Sanjiv Shah, Richard W. Heidebrecht, Benito Muñoz · 2010 · Methods and principles in medicinal chemistry
  80. Chapter 5.7 Aging, Alzheimer's disease and frameshift mutations
    1999 · Techniques in the behavioral and neural sciences
  81. Chapter 1 Genetic Contributions to the Pathogenesis of Alzheimer's Disease
    Mark P. Mattson · 1999 · Advances in cell aging and gerontology
  82. [The scavenger receptor and its importance in amyloid processes].
    Rocío Aguilar-Gaytán, Jaime Mas‐Oliva · 2002 · PubMed
  83. Shock membrane electropotential drops and limited diffusive distance of β-amyloids in cerebral neurons are detrimental enhancement to Alzheimer's diseases
    Chi-huan Chang, Chiung-Huei Peng, Kuan‐Chou Chen, Hsien-Bin Huang, Wen‐Ta Chiu, Robert Y. Peng · 2009 · Colloids and Surfaces B Biointerfaces
  84. Dietary Modulation of Lipid Rafts
    Mark P. Mattson · 2005 · Humana Press eBooks
  85. Amyloid Peptide-Mediated Hypoxic Regulation of Ca2+ Channels in PC12 Cells
    Chris Peers, Kim N. Green, John P. Boyle · 2003 · Advances in experimental medicine and biology
  86. The Involvement of Metal Ions in Copper-Zinc Superoxide Dismutase Related Amyotrophic Lateral Sclerosis
    Megan W. Bourassa · 2012 · Academic Commons (Stony Brook University)
  87. PHYSICO-CHEMICAL OPTIMIZATION AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF ALDEHYDE-DERIVED N-ACYLHYDRAZONES: TOWARDS THE IMPROVEMENT OF MODERATE METAL CHELATORS AS A STRATEGY AGAINST METAL-ENHANCED AGGREGOPATHIES
    Daphne Schneider Cukierman · 2021
  88. New therapeutic patents for Alzheimer’s disease
    1998 · Expert Opinion on Therapeutic Patents
  89. Lésions sélectives de deux populations de neurones affectées dans la maladie d’Alzheimer : impact sur les performances cognitives et l’histopathologie des souris tg2576
    Nour Yassine · 2011 · OpenGrey (Institut de l'Information Scientifique et Technique)
  90. Untersuchungen über die Auswirkungen von Geschlecht und genetischem Hintergrund auf die Alzheimerpathologie im 5xFAD-Mausmodell
    Philipp Johannes Nordmeyer · 2015
  91. Molecular Genetics and Molecular Biology of Alzheimer’s Disease
    Rupert Sandbrink, Konrad T. Beyreuther · 2001 · Springer eBooks
  92. Vascular aspects of Alzheimer's disease: role of oxidative stress on vascular miocytes B-amyloid production and B-amyloid-induced toxicity in endothelial cells
    Mireia Coma · 2007 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  93. Developmental Lead Exposure, Epigentics and Late Onset Alzheimer's Disease
    Nasser H. Zawia, Riyaz M. Basha · 2010
  94. Chapter 3 Cellular calcium dynamics
    Katsutoshi Furukawa, Yue Wang, Sic L. Chan · 2002 · Advances in cell aging and gerontology
  95. Plants and their chemical compounds affecting betha-amyloid and secretase activity as potential sources of neuroprotective herbal medicinal products. Part 1
    Marcin Ożarowski, Przemysław Łukasz Mikołajczak, Anna Bogacz, Radosław Kujawski, Przemysław Michał Mrozikiewicz · 2010 · Herba Polonica
  96. Deregulation of oxidative phosphorylation system and energy homeostasis in Alzheimer's disease
    Virginie F. Rhein · 2009 · edoc (University of Basel)
  97. Telomerase in brain development and neurodegenerative disorders
    Mark P. Mattson, Mahendra S. Rao, Weiming Fu, Wolfram Klapper · 2001 · Advances in cell aging and gerontology
  98. Traumatic brain injury with particular reference to diffuse traumatic axonal injury subpopulations
    Omer Hussain al-Hasani · 2011 · ERA
  99. Dissecting out the contribution of cognitive, social, and physical activities to environmental enrichment's ability to protect Alzheimer's mice against cognitive impairment
    Jennifer R. Cracchiolo · 2005 · Digital Commons - University of South Florida (University of South Florida)
  100. Protein misfolding and amyloid formation
    Charlotte Nerelius · 2009 · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences))